Document Detail


Antimicrobial susceptibility of skin-colonizing S. aureus strains in children with atopic dermatitis.
MedLine Citation:
PMID:  15482526     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Children with atopic dermatitis (AD) are prone to recurrent cutaneous and occasional systemic infections caused by Staphylococcus aureus. Antibiotic therapy represents an important component of the overall management of AD, especially during exacerbations of disease. Erythromycin is still widely used as a first-line antibiotic for this indication. We studied 115 consecutive children (mean age: 2.7 yr, range: 0.2-15) with moderate to severe AD (mean SCORAD: 43.2, range: 16-77) presenting to our outpatient department. Staphylococcus aureus was isolated from 100 of 115 (87%). Antimicrobial susceptibility testing revealed resistance against erythromycin in 18 and against roxithromycin in 19%, respectively. Six percentage of the strains were resistant or only intermediately susceptible to fusidic acid, 13% to amoxicillin and 1% to clindamycin. All strains isolated were susceptible to oxacillin, amoxicillin/clavulanic acid, cefadroxil and cefuroxim. The high rate of primary resistance to macrolides should be born in mind when starting antibiotic therapy in children with AD. Since Gram-positive cocci represent the only relevant microbial agents in AD, first generation cephalosporins such as cefadroxil, whose antimicrobial spectrum is basically restricted to Gram-positive bacteria, would appear to be the ideal first-line antibiotics for the treatment of bacterial superinfections.
Authors:
Peter H Hoeger
Related Documents :
19223196 - Drug delivery strategies for photodynamic antimicrobial chemotherapy: from benchtop to ...
10829216 - Emerging multiresistant strains: recommended precautions in the emergency room and surg...
21722146 - Emergence and spread of antibiotic resistance following exposure to antibiotics.
3299646 - Resistance of bacteria to antibacterial agents: report of task force 2.
1920606 - Comparative in vitro susceptibility of bacteroides and fusobacterium isolated from foot...
2112896 - Characterization of cryptic plasmids from marine cyanobacteria and construction of a hy...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology     Volume:  15     ISSN:  0905-6157     ISO Abbreviation:  Pediatr Allergy Immunol     Publication Date:  2004 Oct 
Date Detail:
Created Date:  2004-10-14     Completed Date:  2005-02-01     Revised Date:  2008-05-28    
Medline Journal Info:
Nlm Unique ID:  9106718     Medline TA:  Pediatr Allergy Immunol     Country:  England    
Other Details:
Languages:  eng     Pagination:  474-7     Citation Subset:  IM    
Affiliation:
Department of Dermatology, Division of Paediatric Dermatology, University of Hamburg, 20246 Hamburg, Martinistr 52, Germany. hoeger@uke.uni-hamburg.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Anti-Bacterial Agents / pharmacology*
Child
Child, Preschool
Dermatitis, Atopic / immunology*
Drug Resistance, Bacterial / immunology*
Erythromycin / pharmacology
Humans
Infant
Microbial Sensitivity Tests
Roxithromycin / pharmacology
Staphylococcal Skin Infections / epidemiology
Staphylococcus aureus / drug effects*
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 114-07-8/Erythromycin; 80214-83-1/Roxithromycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Montelukast and airway remodeling in children with chronic persistent asthma: an open study.
Next Document:  Management of hepatitis C virus genotype 4.